FDA Adverse Event Malfunction Summary report: N

BIOCELL TEXTURED BREAST IMPLANTS AND TISSUE EXPANDERS

MDR report key: 9379557 · Received November 26, 2019

Report

Report Number
9617229-2019-20473
Event Type
Malfunction
Date Received
November 26, 2019
Date of Event
July 22, 2019
Report Date
November 26, 2019
Manufacturer
ALLERGAN (COSTA RICA)
Product Code
FWM
PMA / PMN Number
P990074
Removal / Correction Number
2011068-7/2/19-001-R
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS REPORT IS APPLICABLE TO ALL BIOCELL TEXTURED BREAST IMPLANTS AND TISSUE EXPANDERS WHICH INCLUDES PROCODES FTR, FWM, AND LCJ. ALLERGAN IS SUBMITTING THIS 5-DAY MDR IN ACCORDANCE WITH 21 CFR 803 FOLLOWING THE CLASS I RECALL OF BIOCELL® TEXTURED BREAST IMPLANTS AND TISSUE EXPANDERS DUE TO THE UNCOMMON INCIDENCE OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA (BIA-ALCL). ALLERGAN DID NOT SUBMIT THIS MDR WITHIN 5 WORK DAYS OF THE DECISION TO INITIATE THE REMEDIAL ACTION. ALLERGAN HAS INITIATED NC # (B)(4) TO INVESTIGATE THE LATE 5-DAY MDR RELATED TO 2011068-7/2/19-001-R.

Description of Event or Problem · 1

FDA NOTIFIED ALLERGAN OF RECENTLY UPDATED GLOBAL SAFETY INFORMATION CONCERNING THE UNCOMMON INCIDENCE OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA (BIA-ALCL). BASED ON THE CURRENTLY AVAILABLE INFORMATION, INCLUDING THE NEWLY SUBMITTED DATA, FDA ANALYSIS DEMONSTRATES THAT THE RISK OF BIA-ALCL WITH ALLERGAN BIOCELL TEXTURED IMPLANTS IS APPROXIMATELY 6 TIMES THE RISK OF BIA-ALCL WITH TEXTURED IMPLANTS FROM OTHER MANUFACTURERS MARKETING IN THE U.S. AND CONTINUED DISTRIBUTION OF ALLERGAN'S BIOCELL TEXTURED BREAST IMPLANTS WOULD LIKELY CAUSE SERIOUS, ADVERSE HEALTH CONSEQUENCES AND POTENTIALLY DEATH FROM BIA-ALCL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1174063 BIOCELL TEXTURED BREAST IMPLANTS AND TISSUE EXPANDERS PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE FWM ALLERGAN (COSTA RICA) NA

Patients

Seq Age Sex Outcome Treatment
1 Life Threatening| O| R